Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets

Share Article

The global epigenetics market is segmented into product segments of enzymes, instruments & consumables, kits, and reagents. http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

MarketsandMarkets

MarketsandMarkets

Major Players are Diagenode (Belgium), EMD Millipore (U.S.), Illumina (U.S.), New England Biolabs (U.S.), QIAGEN (Netherlands), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), and Zymo Research (U.S.)

Epigenetics finds applications in a large number of fields of life science research, including oncology, drug discovery, developmental biology, and research for metabolic and genetic disorders. It is rapidly emerging as one of the most widely used techniques for the discovery and development of cancer biomarkers. According to GLOBOCAN, the prevalence of cancer is rapidly growing worldwide. In 2012, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer (within five years of diagnosis) globally. The rapid growth in cancer prevalence has given rise to increased research interest in this field and boosted funding for oncology research. These will be the primary drivers of the epigenetics market between 2014 and 2019.

Get Full Report @ http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

Epigenetics finds applications in oncology, drug discovery, developmental biology, and research of metabolic and genetic disorders. Rapid growth in the research interest in oncology, along with growing partnerships between biotechnology and pharmaceutical companies for the development of epigenetics-based products, will drive the growth of the global epigenetics market

Report Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=896

North America accounted for the largest share of the global epigenetics market in 2014. The Asian market is expected to grow at the highest CAGR during the forecast period, and represents new revenue pockets for players in the global epigenetics market. Asia is expected to witness a steady year-on-year growth owing to the increased R&D funding in this region. It experienced one of the fastest growths in R&D investments in recent years. According to Battelle (an R&D magazine), investments in R&D in Asia increased by 7% between 2009 and 2014. This will drive the growth of the Asian epigenetics market.

The oncology research segment accounted for the largest share of the epigenetics market in 2014, while the drug discovery research segment is expected to grow at the highest CAGR between 2014 and 2019. Drug discovery shows significant growth opportunities for players in the epigenetics market in the forecast period. In the epigenetics product market, the kits segment had the largest share in 2014 and is expected to grow at the highest CAGR between 2014 and 2019. With the increase in research interest, epigenetics is quickly transitioning into a kit-based research field.

PDF Manual @ http://www.marketsandmarkets.com/pdfdownload.asp?id=896

The global epigenetics market is a growing market. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by all players in this market, except Active Motif (U.S.), which did not launch any new products between 2011 and 2014.

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
e-mail: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
@marketsmarkets
since: 04/2009
Follow >
Market Research Report
since: 12/2010
Like >
Follow us on
Visit website